Emerging Stocks Down Under 30 November 2021: Nearmap, Clarity Pharmaceuticals, Pacific Edge
Nearmap: Medium term upside in a downtrendIn today's edition of Emerging Stocks Down Under, aerial imaging company Nearmap has been on a longer term downtrend. But we believe there may be upside to $1.90-2.00 within that downtrend in the near to medium term. Also in today's edition, radiopharmaceutical company Clarity Pharmaceuticals (ASX: CU6) and cancer diagnostics company Pacific Edge (ASX: PEP).
Click here to read the previous edition of Emerging Stocks Down Under published 23 November 2021
Please register or upgrade your plan to access this content.